Tumor Absorbed Dose-Response Relationship in Patients Treated With 177Lu-DOTATATE for Meningioma

Description:

The hypothesis for this study is that there is a dose-response relationship in patients treated with 177Lu-DOTATATE for meningiomas.

Sponsor:

Central Hospital, Nancy, France

Contacts:

Boursier Caroline, MD

c.boursier@chru-nancy.fr

+33383154276

Véronique ROCH, MSC

v.roch@chru-nancy.fr

+33383154276

Government Study Link:

NCT06614205 - Click here to see study on

ClinicalTrials.gov

177Lu-Dotatate

Isotope(s):

Target(s):

Ligand: Peptides

Chelator: DOTA

Contact XCancer: 402-991-8468